Medication info
Twinspin Tablets 40/10mg

Twinspin Tablets 40/10mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White to light yellow and light blue, double convex oval-shaped tablet
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 201606345 · Approved 2016.10.31 · Insurance code 643104230

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients for whom this medicine should be administered with caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or telmisartan. This drug effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases caused by hypertension. It contributes to the safe management of blood pressure and the prevention of complications, making it an essential medication for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients for whom this medicine should be administered with caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication should not be used by pregnant women, especially in the second and third trimesters, as it can pose serious risks to the fetus. It should not be administered to patients with certain conditions, such as liver impairment, obstructive biliary disease, severe hypotension, heart failure, and unstable state after acute myocardial infarction. Caution should be exercised in administering to patients with primary aldosteronism, certain heart valve diseases, impaired liver function, gastrointestinal diseases, renal artery hypertension, kidney failure, and elderly patients. When taking this medication, side effects such as dizziness or peripheral edema may occur, and serious adverse reactions such as syncope may rarely occur, so caution is advised. This medication should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with alternative treatments. In patients with insufficient body fluids or sodium, hypotension may occur, so the state should be carefully checked before administration, and appropriate measures should be taken if hypotension occurs. Due to the risk of hyperkalemia, potassium levels in the blood should be monitored regularly, and caution should be exercised when used with potassium supplements or potassium-containing medications. Patients with impaired renal function should have renal function changes monitored regularly, and patients with heart disease should be careful to prevent blood pressure from dropping too low. This medication may cause drowsiness or dizziness; hence, caution is needed when driving or operating dangerous machinery. When used in combination with other medications, there may be potential interactions, so it is important to consult healthcare professionals, especially when using with certain diuretics, lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs, to closely monitor blood concentration and renal function. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, or in severe cases, acute kidney failure may occur, so immediate medical attention is necessary. The safety and efficacy in children have not been sufficiently established, and its use is therefore not recommended for pediatric patients. Elderly patients may be more sensitive to treatment, so dosage adjustments and monitoring are necessary. When storing this medication, keep it out of the reach of children and avoid transferring the product to other containers.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver damage
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • acute renal failure
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to pass through. Additionally, it is advisable to keep the medication at room temperature between 1 degrees Celsius and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White to light yellow and light blue, double convex oval-shaped tablet

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.